SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-200830
Filing Date
2011-07-28
Accepted
2011-07-28 16:09:42
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 634482
2 COLLABORATION AND LICENSE AGREEMENT - HALOZYME INC. DATED MAY 10, 2011 dex101.htm EX-10.1 178983
3 SECOND AMENDMENT TO PROJECT AGREEMENT NO.2 dex102.htm EX-10.2 23959
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9584
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9574
6 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 3988
  Complete submission text file 0001193125-11-200830.txt   5263063

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vphm-20110630.xml EX-101.INS 739353
8 XBRL TAXONOMY EXTENSION SCHEMA vphm-20110630.xsd EX-101.SCH 41232
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vphm-20110630_cal.xml EX-101.CAL 44996
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vphm-20110630_def.xml EX-101.DEF 150991
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vphm-20110630_lab.xml EX-101.LAB 366119
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vphm-20110630_pre.xml EX-101.PRE 302238
Mailing Address 730 STOCKTON DRIVE EXTON PA 19341
Business Address 730 STOCKTON DRIVE EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

IRS No.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21699 | Film No.: 11993830
SIC: 2834 Pharmaceutical Preparations